We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Refine your search

Content type

Tags

Author

4 results found

Article

Borden Ladner Gervais LLP | Canada | 26 Oct 2016

Are Private Placements the new poison pill? No, but they may cause some indigestion

On October 24, 2016, the British Columbia Securities Commission and Ontario Securities Commission (the "Commissions") issued reasons for their July 22

Article

Borden Ladner Gervais LLP | Canada | 17 Jan 2011

The Ontario Securities Commission rejects deference to target boards in poison pill decisions

The Ontario Securities Commission's reasons in Baffinland Iron Mines Corporation clearly rejected the proposition that securities commissions should defer to the business judgment of a target board of directors in deciding whether to cease trade a shareholder rights plan (also known as a poison pill).

Previous page 1 Next page